Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-α Levels in Women with Polycystic Ovary Syndrome: A Pilot Study-Reference-Cited by-同舟云学术

Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-α Levels in Women with Polycystic Ovary Syndrome: A Pilot Study

Published:2017-02 Issue:1 Volume:30 Page:58-62
ISSN:1083-3188
Container-title:Journal of Pediatric and Adolescent Gynecology
language:en
Short-container-title:Journal of Pediatric and Adolescent Gynecology

Author:

Yousuf Syed Douhath,Rashid Fouzia,Mattoo Tahira,Shekhar Chander,Mudassar Syed,Zargar M. Afzal,Ganie Mohd Ashraf

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,General Medicine,Pediatrics, Perinatology and Child Health

Reference48 articles.

1. The prevalence and features of the polycystic ovary syndrome in an unselected population;Azziz;J Clin Endocrinol Metab,2004

2. Prevalence of polycystic ovarian syndrome in Indian adolescents;Nidhi;J Pediatr Adolesc Gynecol,2011

3. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India;Joshi;Indian J Endocrinol Metab,2014

4. Inflammation in polycystic ovary syndrome; underpinning of insulin resistance and ovarian dysfunction;Gonzalez;Steroids,2012

5. Screening for insulin resistance in polycystic ovary syndrome: views of physician members of the American Society for Reproductive Medicine;Asante;J Reprod Med,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Oral Contraceptives Consumption with C-Reactive Protein (CRP), Tumor Necrosis Factor-Î± (TNF-Î±) and Interleukin (IL-6) in Female in vivo Model;International Journal of Biological Chemistry;2024-07-12

2. Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women;BMC Women's Health;2023-02-15

3. SÍNDROME DO OVÁRIO POLICÍSTICO ASSOCIADA À OBESIDADE: MECANISMOS FISIOPATOLÓGICOS E IMPLICAÇÕES CLÍNICAS – UMA REVISÃO INTEGRATIVA;RECISATEC - REVISTA CIENTÍFICA SAÚDE E TECNOLOGIA - ISSN 2763-8405;2022-09-11

4. Association of -675 4G/5G PAI-1 and -2518A/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study;Journal of Family Medicine and Primary Care;2022

5. Role of Seed Cycling in Polycystic Ovaries Syndrome;Pakistan BioMedical Journal;2021-12-31